Raymond James & Associates’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-13,096
| Closed | -$51K | – | 4014 |
|
|
2021
Q3 | $51K | Buy |
+13,096
| New | +$51K | ﹤0.01% | 3847 |
|
|
2020
Q4 | – | Sell |
-27,740
| Closed | -$74K | – | 3653 |
|
|
2020
Q3 | $74K | Hold |
27,740
| – | – | ﹤0.01% | 3365 |
|
|
2020
Q2 | $85K | Hold |
27,740
| – | – | ﹤0.01% | 3278 |
|
|
2020
Q1 | $54K | Hold |
27,740
| – | – | ﹤0.01% | 3271 |
|
|
2019
Q4 | $79K | Buy |
27,740
+650
| +2% | +$1.85K | ﹤0.01% | 3455 |
|
|
2019
Q3 | $99K | Buy |
+27,090
| New | +$99K | ﹤0.01% | 3357 |
|
|
2018
Q1 | – | Sell |
-18,090
| Closed | -$60K | – | 3377 |
|
|
2017
Q4 | $60K | Buy |
+18,090
| New | +$60K | ﹤0.01% | 3208 |
|